Immune-mediated pathways in chronic inflammatory arthritis.
Rheumatoid arthritis (RA) is the prototype chronic inflammatory arthropathy; its precise aetiology is unknown. Over recent years, a number of crucial advances in our understanding of the disease have had a major impact on the treatment of patients with RA.
Gorman
Claire L
CL
The Kennedy Institute of Rheumatology, Faculty of Medicine, Imperial College, 1 Aspenlea Road, Hammersmith, London W6 8LH, UK. c.gorman@imperial.ac.uk <c.gorman@imperial.ac.uk>
Cope
Andrew P
AP
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D015551:Autoimmunity / Q000276:immunology; D001402:B-Lymphocytes / Q000502:physiology; D018925:Chemokines / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000276:immunology; D013583:Synovial Membrane / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology; D051193:Toll-Like Receptors / Q000276:immunology
D018925:Chemokines; D051193:Toll-Like Receptors